Skip to content
OpenCapital
Get started

MacroGenics MGNX Q4 2024 Annual earnings

Reported March 20, 2025 · After market close

Revenue$17.7MMiss by $16.4MDiluted EPS-$0.25Miss by $0.02
Revenue estimate$34.2M
EPS estimate-$0.23

Next report

Aug 13, 2026 (in a month)
Revenue estimate$68.0M
EPS estimate$0.03

Versus estimates

Revenue

Q1 2026$20.8MBeat by $5.5MQ4 2025$41.2MBeat by $6.6MQ3 2025$72.8MBeat by $45.0MQ2 2025$22.2MMiss by $2.2MQ1 2025$13.2MBeat by $1.4M
Q4 2024$17.7MMiss by $16.4M

Diluted EPS

Q1 2026-$0.58Miss by $0.01Q4 2025-$0.22Beat by $0.20Q3 2025$0.27Beat by $0.75Q2 2025-$0.57Beat by $0.02Q1 2025-$0.65Miss by $0.04
Q4 2024-$0.25Miss by $0.02

Ask the moment MacroGenics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MacroGenics report Q4 2024 earnings?
MacroGenics (MGNX) reported Q4 2024 earnings on March 20, 2025 after market close.
What were MacroGenics's Q4 2024 revenue and EPS?
MacroGenics reported revenue of $17.7M and diluted EPS of $-0.25 for Q4 2024.
Did MacroGenics beat estimates in Q4 2024?
Revenue missed the consensus estimate of $34.2M by $16.4M. EPS missed the consensus estimate of $-0.23 by $0.02.
Where can I find MacroGenics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001125345-25-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.